Zenas Biopharma Inc
ZBIO16.809USD
+1.399+9.08%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
703.00MMarket Cap
LossP/E TTM
Zenas Biopharma Inc
16.809
+1.399+9.08%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-93.96%-37.05M
-150.35%-38.55M
-197.53%-31.06M
-48.04%-30.96M
26.71%-19.10M
10.08%-15.40M
--31.85M
---20.91M
---26.06M
---17.13M
Net income from continuing operations
-20.77%-33.57M
-113.95%-52.60M
-208.43%-38.61M
-30.74%-37.98M
-45.57%-27.80M
-29.45%-24.59M
--35.61M
---29.05M
---19.10M
---18.99M
Operating gains losses
-30.30%23.00K
10.00%33.00K
38.46%36.00K
20.69%35.00K
17.86%33.00K
20.00%30.00K
--26.00K
--29.00K
--28.00K
--25.00K
Other non-cash items
-185.53%-136.00K
-321.94%-344.00K
-27.75%125.00K
-98.64%139.00K
-16.75%159.00K
-49.84%155.00K
--173.00K
--10.21M
--191.00K
--309.00K
Change in working capital
-229.03%-8.86M
17.17%8.87M
191.54%4.54M
286.14%5.16M
187.21%6.87M
508.28%7.57M
---4.96M
---2.77M
---7.87M
--1.24M
-Change in prepaid expenses
-119.75%-353.00K
-698.97%-8.18M
159.33%1.79M
-286.78%-3.10M
299.66%1.79M
100.74%1.36M
---3.02M
---802.00K
---895.00K
--680.00K
-Change in other current liabilities
----
----
---530.00K
---970.00K
--1.50M
----
----
--0.00
--0.00
----
Cash from non-recurring investing activities
Cash from operating activities
-93.96%-37.05M
-150.35%-38.55M
-197.53%-31.06M
-48.04%-30.96M
26.71%-19.10M
10.08%-15.40M
--31.85M
---20.91M
---26.06M
---17.13M
Investing cash flow
Net cash from continuing investing activities
-18.18%18.00K
335.29%74.00K
--0.00
--35.00K
--22.00K
-98.42%17.00K
--0.00
--0.00
--0.00
--1.07M
Capital expenditures
-18.18%18.00K
335.29%74.00K
--0.00
--35.00K
--22.00K
-98.42%17.00K
--0.00
--0.00
--0.00
--1.07M
Net cash flow from disposal of fixed assets
-18.18%18.00K
335.29%74.00K
--0.00
--35.00K
--22.00K
-77.03%17.00K
--0.00
--0.00
--0.00
--74.00K
Net cash flow from intangible asset transactions
----
----
----
----
----
-100.00%0.00
----
----
----
--1.00M
Net cash flow from investment products
---86.26M
---3.66M
---26.76M
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-392054.55%-86.27M
-21870.59%-3.73M
---26.76M
---35.00K
---22.00K
98.42%-17.00K
--0.00
--0.00
--0.00
---1.07M
Financing cash flow
Cash flow from continuous financing activities
116.12%99.00K
3606.00%1.85M
1069.90%233.98M
1615709.09%177.74M
-1216.36%-614.00K
-99.92%50.00K
--20.00M
--11.00K
--55.00K
--59.39M
Net cash flow from debt Issuance/repayment
----
----
-100.00%0.00
----
----
--0.00
--20.00M
----
----
--0.00
Net cash flow from common stock issuance/repurchase
----
--6.25M
--234.39M
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
--0.00
--0.00
--178.38M
----
----
--0.00
----
----
--59.39M
Proceeds from stock option exercised by employees
135.71%99.00K
54.00%77.00K
--32.00K
1027.27%124.00K
-23.64%42.00K
--50.00K
--0.00
--11.00K
--55.00K
--0.00
Net cash flow from other financing activities
----
---4.47M
---439.00K
---766.00K
---656.00K
----
--0.00
--0.00
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
116.12%99.00K
3606.00%1.85M
1069.90%233.98M
1615709.09%177.74M
-1216.36%-614.00K
-99.92%50.00K
--20.00M
--11.00K
--55.00K
--59.39M
Net cash flow
Beginning cash balance
461.68%319.83M
397.43%360.13M
795.60%184.02M
-9.79%37.24M
-15.38%56.94M
177.52%72.40M
--20.55M
--41.28M
--67.30M
--26.09M
Current period cash flow changes
-525.71%-123.28M
-160.74%-40.30M
239.65%176.11M
807.87%146.78M
24.26%-19.70M
-137.50%-15.45M
--51.85M
---20.73M
---26.01M
--41.21M
Effect of exchange rate changes
-244.44%-52.00K
262.07%141.00K
-1400.00%-52.00K
-80.72%32.00K
820.00%36.00K
-583.33%-87.00K
--4.00K
--166.00K
---5.00K
--18.00K
Ending cash balance
427.80%196.55M
461.67%319.83M
397.43%360.13M
795.60%184.02M
-9.79%37.24M
-15.38%56.94M
--72.40M
--20.55M
--41.28M
--67.30M
Free cash flow
-93.83%-37.07M
-150.55%-38.63M
-197.53%-31.06M
-48.21%-30.99M
26.62%-19.12M
15.30%-15.42M
--31.85M
---20.91M
---26.06M
---18.20M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
